You are here: Industry Insights > IPO

News List

Moderna shares slide after record $604m US listing pharmaphorum
December 11, 2018
RNA drug specialist Moderna smashed the record for an initial public offering (IPO) in the US on Friday, raising a whopping $604 million, although its shares retreated 19% after the debut......
After delayed IPO, Mereo gets US listing via OncoMed merger pharmaphorum
December 10, 2018
UK biotech Mereo BioPharma is merging with Californian biotech OncoMed in an all-stock deal that swells its pipeline and gives it a potential licensing deal with Celgene......
Europe's biggest private biotech company raises $270 million biospectrumasia
November 29, 2018
Europe’s largest privately held biotech company, Germany-based BioNTech, has raised $270 million to support its work in developing personalized immunotherapies for cancer...
Europe's biggest private biotech company raises $270 million biospectrumasia
November 23, 2018
Europe's biggest private biotech company raises $270 million BioNTech has already signed a $310 million deal with Roche
Europe's biggest private biotech company raises $270 million biospectrumasia
November 20, 2018
Europe's biggest private biotech company raises $270 million BioNTech has already signed a $310 million deal with Roche
Preclinical biotech Synthorx wants a $100M IPO fiercebiotech
November 15, 2018
Moderna will be getting all the headlines for its monster $500 million IPO attempt this week, but that shouldn’t overshadow the major $100 million IPO that early-stage Synthorx has just announced, and what this says about the biotech market.
Preclinical biotech Synthorx wants a $100M IPO fiercebiotech
November 15, 2018
Moderna will be getting all the headlines for its monster $500 million IPO attempt this week, but that shouldn’t overshadow the major $100 million IPO that early-stage Synthorx has just announced, and what this says about the biotech market.
Nicox pauses Nasdaq IPO plan amid market volatility fiercebiotech
November 02, 2018
Nicox has pulled out of a planned Nasdaq listing. The French biotech began gearing up to offer stock on Nasdaq earlier this year but has now hit pause on the plan in response to ...
5 months after launch, Allogene guns for $100M IPO fiercebiotech
September 18, 2018
Allogene licensed its allogeneic CAR-T pipeline from Cellectis by way of Pfizer.
Is Moderna prepping for biotech's biggest-ever IPO? fiercebiotech
September 14, 2018
Modera Therapeutics is one of a select group of biotech "unicorns."

Previous page 1 2 3 4 5 6 7 8 9 Next page